Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketing.
Brinker
Allen
A
Staffa
Judy
J
D000890:Anti-Infective Agents / Q000592:standards / Q000627:therapeutic use*; D001372:Aza Compounds; D002986:Clinical Trials as Topic; D004348:Drug Labeling / Q000592:standards; D024841:Fluoroquinolones; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D000077266:Moxifloxacin; D015242:Ofloxacin / Q000592:standards / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing / Q000592:standards; D011804:Quinolines; D014481:United States; D014486:United States Food and Drug Administration
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D015242:Ofloxacin; D000077266:Moxifloxacin